Get started
Author

Rachel A. Burga

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases
2015 · Steven C. Katz, Rachel A. Burga, et al. · Clinical Cancer Research · 397
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
2015 · Rachel A. Burga, Mitchell Thorn, et al. · Cancer Immunology Immunotherapy · 230
A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration
2012 · Nora T. Khanarian, Nora M. Haney, et al. · Biomaterials · 153
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
2016 · Juliana Cano-Mejia, Rachel A. Burga, et al. · Nanomedicine Nanotechnology Biology and Medicine · 146
PDF
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
2017 · Eric S. Yvon, Rachel Burga, et al. · Cytotherapy · 135
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
2021 · Jason Miska, Aida Rashidi, et al. · Science Advances · 115
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
2019 · Rachel A. Burga, Eric Yvon, et al. · Clinical Cancer Research · 85
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
2020 · Catalina Lee-Chang, Jason Miska, et al. · The Journal of Experimental Medicine · 74
Conjugating Prussian Blue Nanoparticles Onto antigen-specific T Cells As a Combined Nanoimmunotherapy
2016 · Rachel A Burga, Shabnum Patel, et al. · Nanomedicine · 64
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
2019 · Shabnum Patel, Rachel A. Burga, et al. · Frontiers in Oncology · 60
PDF
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils
2013 · Lauren A Licata, Cang T Nguyen, et al. · Journal of Leukocyte Biology · 49
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
2019 · Allison B. Powell, Sridevi Yadavilli, et al. · Journal of Translational Medicine · 45
PDF
Composite iron oxide–Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors
2017 · Shraddha Kale, Rachel Burga, et al. · International Journal of Nanomedicine · 40
PDF
Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases
2014 · A Saied, L Licata, et al. · Cancer Gene Therapy · 39
Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide Nanoparticles
2019 · Rachel A. Burga, Daud H. Khan, et al. · Bioconjugate Chemistry · 34
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
2016 · Elizabeth E. Sweeney, Rachel A. Burga, et al. · Scientific Reports · 34
PDF
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells
2016 · Rachel A. Burga, Tuongvan Nguyen, et al. · Cytotherapy · 31
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
2013 · Steven C Katz, Rachel A Burga, et al. · Journal of Translational Medicine · 27
PDF
An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model
2021 · Anshi Shukla, Juliana Cano-Mejia, et al. · Advanced NanoBiomed Research · 23
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function
2020 · Elizabeth E. Sweeney, Preethi B. Balakrishnan, et al. · Nano Research · 23
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
2021 · Alex Cordero, Matthew D. Ramsey, et al. · Proceedings of the National Academy of Sciences · 18
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15
2025 · Rachel A. Burga, Bulent Arman Aksoy, et al. · Molecular Therapy · 17
Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells
2014 · Mitchell Thorn, Gary R Point, et al. · Journal of Leukocyte Biology · 16
Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation
2024 · Rodabe N. Amaria, Krishna V. Komanduri, et al. · Cytotherapy · 14
OBX-115 engineered tumor-infiltrating lymphocytes (TIL) with regulatable membrane-bound IL15 (mbIL15): Translational data from a single-center phase 1 trial in patients (pts) with immune checkpoint inhibitor (ICI)–resistant advanced melanoma.
2025 · Rodabe Navroze Amaria, Adi Diab, et al. · Journal of Clinical Oncology · 5
PDF
Works count: 94
Citation count: 1,899
H-index: 20
I10-index: 24
Year
Topic
Type